Table 1.
Reference | Sex, age | Tracer | Vaccination | Days between vaccination and examination | Main findings at PET/CT | Injection site uptake | Hypermetabolic lymph nodes |
---|---|---|---|---|---|---|---|
[8] | F, 35 yr | [18F]FDG | 1st administration of mRNA-1273 | 10 | Thymic hyperplasia | nr | Yes |
[9] | M, 67 yr | [18F]FDG | 2nd administration of mRNA-1273 | 4 | Radiation recall pneumonitis | nr | nr |
[10] | F, 46 yr | [18F]FDG | nr | 7 | Splenic and bone marrow uptake | nr | Yes |
[11] | F, 65 yr | [18F]FDG | 1st administration of mRNA-1273 | 5 | Splenic uptake | Yes | Yes |
[7] | M, 18 yr | [68Ga]Ga-DOTATOC | 2nd administration of mRNA-1273 | 2 | Myocarditis | nr | nr |
M, 21 yr | 2nd administration of BNT162b2 | 3 | nr | nr | |||
[6] | F, 78 yr | [18F]FDG | 1st administration of mRNA-1273 | nr | Rheumatic polymyalgia | nr | nr |
F, female; M, male; nr, not reported; yr, years